OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Post‐COVID ‐19 Parkinsonism in the Future?
A. V. Boika
Movement Disorders (2020) Vol. 35, Iss. 7, pp. 1094-1094
Open Access | Times Cited: 29
A. V. Boika
Movement Disorders (2020) Vol. 35, Iss. 7, pp. 1094-1094
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Cognitive decline among individuals with history of mild symptomatic SARS‐CoV‐2 infection: A longitudinal prospective study nested to a population cohort
Óscar H. Del Brutto, Shasha Wu, Robertino M. Mera, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 10, pp. 3245-3253
Open Access | Times Cited: 161
Óscar H. Del Brutto, Shasha Wu, Robertino M. Mera, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 10, pp. 3245-3253
Open Access | Times Cited: 161
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review
Eleni Korompoki, Maria Gavriatopoulou, Rachel Hicklen, et al.
Journal of Infection (2021) Vol. 83, Iss. 1, pp. 1-16
Open Access | Times Cited: 158
Eleni Korompoki, Maria Gavriatopoulou, Rachel Hicklen, et al.
Journal of Infection (2021) Vol. 83, Iss. 1, pp. 1-16
Open Access | Times Cited: 158
Parkinson’s Disease and the COVID-19 Pandemic
Conor Fearon, Alfonso Fasano
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 431-444
Open Access | Times Cited: 83
Conor Fearon, Alfonso Fasano
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 431-444
Open Access | Times Cited: 83
Relationship between COVID‐19 and movement disorders: A narrative review
Susanne A. Schneider, Anita Hennig, Davide Martino
European Journal of Neurology (2021) Vol. 29, Iss. 4, pp. 1243-1253
Open Access | Times Cited: 47
Susanne A. Schneider, Anita Hennig, Davide Martino
European Journal of Neurology (2021) Vol. 29, Iss. 4, pp. 1243-1253
Open Access | Times Cited: 47
Parkinsonism: An emerging post COVID sequelae
Abhijith Rajaram Rao, Shaik Mohammed Hidayathullah, Karan Hegde, et al.
IDCases (2022) Vol. 27, pp. e01388-e01388
Open Access | Times Cited: 35
Abhijith Rajaram Rao, Shaik Mohammed Hidayathullah, Karan Hegde, et al.
IDCases (2022) Vol. 27, pp. e01388-e01388
Open Access | Times Cited: 35
Potential convergence of olfactory dysfunction in Parkinson’s disease and COVID-19: The role of neuroinflammation
Hui Li, Junliang Qian, Youcui Wang, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102288-102288
Closed Access | Times Cited: 7
Hui Li, Junliang Qian, Youcui Wang, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102288-102288
Closed Access | Times Cited: 7
Neurological complications caused by SARS-CoV-2
Zehan Pang, Ao Tang, Yujie He, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 6
Zehan Pang, Ao Tang, Yujie He, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 6
De Novo Movement Disorders and COVID ‐19: Exploring the Interface
Ritwik Ghosh, Uttam Biswas, Dipayan Roy, et al.
Movement Disorders Clinical Practice (2021) Vol. 8, Iss. 5, pp. 669-680
Open Access | Times Cited: 36
Ritwik Ghosh, Uttam Biswas, Dipayan Roy, et al.
Movement Disorders Clinical Practice (2021) Vol. 8, Iss. 5, pp. 669-680
Open Access | Times Cited: 36
Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer’s and Parkinson’s Diseases in Young Urbanites Exposed to Air Pollution
Lilian Calderón‐Garcidueñas, Ricardo Torres‐Jardón, Maricela Franco-Lira, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 2, pp. 479-503
Closed Access | Times Cited: 36
Lilian Calderón‐Garcidueñas, Ricardo Torres‐Jardón, Maricela Franco-Lira, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 2, pp. 479-503
Closed Access | Times Cited: 36
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis
Finja Schweitzer, Nina N. Kleineberg, Yasemin Göreci, et al.
Current Opinion in Neurology (2021) Vol. 34, Iss. 3, pp. 423-431
Closed Access | Times Cited: 18
Finja Schweitzer, Nina N. Kleineberg, Yasemin Göreci, et al.
Current Opinion in Neurology (2021) Vol. 34, Iss. 3, pp. 423-431
Closed Access | Times Cited: 18
Movement Disorders Associated with COVID-19
Mehri Salari, Bahareh Zaker Harofteh, Masoud Etemadifar, et al.
Parkinson s Disease (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 16
Mehri Salari, Bahareh Zaker Harofteh, Masoud Etemadifar, et al.
Parkinson s Disease (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 16
Parkinson’s Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment
Aurelian Anghelescu, Gelu Onose, Cristina Raluca Gh. Popescu, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1000-1000
Open Access | Times Cited: 11
Aurelian Anghelescu, Gelu Onose, Cristina Raluca Gh. Popescu, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1000-1000
Open Access | Times Cited: 11
COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection
Salvatore Iacono, Giuseppe Schirò, Chiara Davì, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 5
Salvatore Iacono, Giuseppe Schirò, Chiara Davì, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 5
Parkinson’s Disease in Light of the COVID-19 Pandemic
Anna Drelich‐Zbroja, Mateusz Cheda, Maryla Kuczyńska, et al.
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 143-143
Open Access | Times Cited: 8
Anna Drelich‐Zbroja, Mateusz Cheda, Maryla Kuczyńska, et al.
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 143-143
Open Access | Times Cited: 8
Incidence and characteristics of post-COVID-19 parkinsonism and dyskinesia related to COVID-19 vaccines
Jarosław Dulski, Jaroslaw Sławek
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 53-62
Open Access | Times Cited: 4
Jarosław Dulski, Jaroslaw Sławek
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 53-62
Open Access | Times Cited: 4
Three Patients With Chorea and Positive Voltage-Gated Potassium Channel Antibody: Is This the Link Between Hyperkinetic von Economo Disease and COVID-19?
Jacqueline Dulanto, David Chu, Pardis Saffari, et al.
Cureus (2023)
Open Access | Times Cited: 3
Jacqueline Dulanto, David Chu, Pardis Saffari, et al.
Cureus (2023)
Open Access | Times Cited: 3
Post‐COVID worsening of a Parkinson's disease patient
A. V. Boika, M.M. Sialitski, Veranika Chyzhyk, et al.
Clinical Case Reports (2021) Vol. 9, Iss. 7
Open Access | Times Cited: 8
A. V. Boika, M.M. Sialitski, Veranika Chyzhyk, et al.
Clinical Case Reports (2021) Vol. 9, Iss. 7
Open Access | Times Cited: 8
Autoimmune mediated hyperkinetic movement disorders in SARS-CoV-2 infection — a systematic review
Adam Sebastian Hirschfeld
Neurologia i Neurochirurgia Polska (2021) Vol. 55, Iss. 6, pp. 549-558
Open Access | Times Cited: 8
Adam Sebastian Hirschfeld
Neurologia i Neurochirurgia Polska (2021) Vol. 55, Iss. 6, pp. 549-558
Open Access | Times Cited: 8
Parkinsonism associated with viral infection
Irina Ivan, Laura Irincu, Ştefania Diaconu, et al.
International review of neurobiology (2022), pp. 1-16
Closed Access | Times Cited: 5
Irina Ivan, Laura Irincu, Ştefania Diaconu, et al.
International review of neurobiology (2022), pp. 1-16
Closed Access | Times Cited: 5
Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination
Rupinder Kaur, Shareen Singh, Thakur Gurjeet Singh, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 1-21
Open Access | Times Cited: 4
Rupinder Kaur, Shareen Singh, Thakur Gurjeet Singh, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 1-21
Open Access | Times Cited: 4
Characterizing Secondary and Atypical Parkinsonisms: Defining Features and Clinical Variability
Iraís Viveros-Martínez, Cristofer Zarate-Calderon, Donají Chi-Castañeda, et al.
Neuroglia (2024) Vol. 5, Iss. 4, pp. 467-487
Open Access
Iraís Viveros-Martínez, Cristofer Zarate-Calderon, Donají Chi-Castañeda, et al.
Neuroglia (2024) Vol. 5, Iss. 4, pp. 467-487
Open Access
COVID-19 and Neuroinflammation: A Vital Role for Dance/Movement Therapy in Long-Term Health Outcomes
Shahd A. A. Amro, Rebecca Barnstaple, Shayla Schwartz, et al.
American Journal of Dance Therapy (2023) Vol. 45, Iss. 2, pp. 137-149
Closed Access | Times Cited: 1
Shahd A. A. Amro, Rebecca Barnstaple, Shayla Schwartz, et al.
American Journal of Dance Therapy (2023) Vol. 45, Iss. 2, pp. 137-149
Closed Access | Times Cited: 1
SARS-CoV-2 en el adulto mayor con enfermedad neurodegenerativa
Johanna Lizeth González Devia, Myriam Leonor Torres Pérez, Diana M. Mendez
Nova (2020) Vol. 18, Iss. 35, pp. 121-127
Open Access | Times Cited: 2
Johanna Lizeth González Devia, Myriam Leonor Torres Pérez, Diana M. Mendez
Nova (2020) Vol. 18, Iss. 35, pp. 121-127
Open Access | Times Cited: 2
Neurological complications of SARS-CoV-2 coronavirus infection (COVID-19)
Pavel Otruba, Jan Bardoň, Milan Kolář, et al.
Neurologie pro praxi (2020) Vol. 21, Iss. Suppl. G, pp. 14-14
Closed Access | Times Cited: 2
Pavel Otruba, Jan Bardoň, Milan Kolář, et al.
Neurologie pro praxi (2020) Vol. 21, Iss. Suppl. G, pp. 14-14
Closed Access | Times Cited: 2
High intelligence may exacerbate paediatric inflammatory response to SARS-CoV-2 infection
Pauline McDonagh Hull, Bonnie Lashewicz, Marvin J. Fritzler
Medical Hypotheses (2021) Vol. 155, pp. 110677-110677
Open Access | Times Cited: 2
Pauline McDonagh Hull, Bonnie Lashewicz, Marvin J. Fritzler
Medical Hypotheses (2021) Vol. 155, pp. 110677-110677
Open Access | Times Cited: 2
